Latest News about NASDAQ:LGVN
Recent news which mentions NASDAQ:LGVN
Tickers
LGVN
From InvestorPlace
Tickers
LGVN
From InvestorPlace
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 12, 2023
Tags
NASDAQ:LGVN
From News Direct
Upcoming Phase 2 Data Expected For Longeveron’s (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer’s Sector – What To Look For
September 07, 2023
Tags
NASDAQ:LGVN
From News Direct
Tags
NASDAQ:LGVN
From News Direct
Tickers
LGVN
From InvestorPlace
Why Longeveron’s Good News Isn’t Telling Us the Whole Truth
December 10, 2021
Tickers
LGVN
From InvestorPlace
Even After a Blistering Rally, Longeveron Is Still Buyable
November 30, 2021
Tickers
LGVN
From InvestorPlace
LGVN Stock: 7 Things to Know as Longeveron Rockets 100% Higher
November 24, 2021
Tickers
LGVN
From InvestorPlace
LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today
November 18, 2021
Tickers
LGVN
From InvestorPlace